Trump's global health strategy is emerging. What will the Democratic Congress say?

The Trump administration is shifting U.S. global health strategy from a traditional donor-recipient model to a partnership-based approach. This transition has caused initial instability in aid delivery, and the incoming Democratic Congress is expected to scrutinize the strategy's transparency and impact.
Why it matters
This represents a major pivot in U.S. foreign policy and international development, potentially affecting health outcomes in vulnerable nations.
By all appearances, it was a classic government ceremony. Officials in suits. Big black chairs around a wooden table. A cluster of microphones. It happened on October 8 in Lusaka, Zambia. Amid applause, U.S. and Zambian officials signed a global health agreement, called a Memorandum of Understanding or MOU.
But Mich Coker — the Chargé d'Affaires at the U.S. Embassy in Zambia — said this agreement was anything but classic.
"This MOU represents a fundamental shift," he said, speaking at the signing ceremony . He explained that the relationship between the two countries was moving "from a traditional donor-recipient model to a true partnership, one grounded in Zambian leadership, in Zambian ownership and in shared accountability."
Global health experts on all sides of the political spectrum and all over the world agree with Coker that there's been a fundamental shift in the U.S. approach to global health.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in